Navigation Links
Patients More Willing To Use Self-Injectable HIV Therapy Than Anticipated

Recent study shows that HIV patients are more willing to consider and use self-injectable therapy than many physicians anticipate // .

Initial results from the OpenMind study, the largest behavioural study to look at both patients' and physicians' perceptions of HIV care in treatment-experienced patients, were revealed today at EACS.

The findings are anticipated to help physicians implement improved care to HIV patients and help pave the way for better acceptance and integration of other new innovative drugs such as monoclonal antibodies that are increasingly being developed for the management of HIV and other diseases.

The study was conceived to look at attitudes to FUZEON (enfuvirtide), the first approved HIV fusion inhibitor, and an important option for treatment-experienced patients who face HIV resistance. FUZEON presents unique challenges because it is the first self-injectable antiretroviral whereas all other treatments are oral.

It was found that 76% of patients would consider using a self-injectable HIV therapy if their physician recommended it. However, only 28% of patients who are potentially eligible for FUZEON had actually discussed this injectable option with their physicians. Only 10% of eligible patients were currently prescribed FUZEON, despite the fact that it is recommended in key international HIV treatment guidelines.

This study also identifies some of the main reasons why many physicians may be reluctant to prescribe a treatment of proven efficacy and safety. The reasons include; the physicians' perception that patients would be reluctant to use a self-injectable therapy, the physicians' opinion that the patient would not be able to incorporate FUZEON into their lifestyle and the potential misconception that FUZEON is not appropriately recommended in guidelines.

Rob Horne, Professor of Psychology at the University of Brighton and OpenMind study author, said, "These new insights from th
'"/>




Page: 1 2

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
(Date:7/6/2015)... ... 2015 , ... Respected southern California personal injury attorney Fernando D. Vargas has ... attorney who has sharp legal skills as well as a superior commitment to client ... Martindale-Hubbell and a Top 10 Award from The National Academy of Personal Injury Attorneys ...
(Date:7/6/2015)... ... 2015 , ... On June 22, 2015, Fox News in a report titled “ Female Hair Loss Needs ... 35 a quarter of all women in the U.S. will suffer from thinning hair or ... rarely discussed. One woman, a former beauty queen, who was interviewed for the report began ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Asian-Pacific market for ... It is expected to grow at a CAGR of over 3.2 percent in the ... growth is likely to be mainly spurred by an anticipated launch of a number ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... site allows newly-diagnosed cancer patients, caregivers and medical professionals to chat with the ... the same cancer. , “Receiving a cancer diagnosis is often the most traumatic ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... In ... can learn how to reduce their risk of having a fracture through the bone ... From Fractures Awareness Day. , “We are participating because our residents need this information ...
Breaking Medicine News(10 mins):Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:National Bone Health Screening and Awareness Day 2
... a new twist in its sordid journey. Tracing its beginnings, ... the development of cancer. // It will not be an ... lasting remedy of the diseased tissues. ,Researchers believe that ... malignant tissues. This is probably the reason why a tumor ...
... study has found that hormonal changes due to aging in ... the younger ones.Researchers at Vrije University Medical Centre in the ... of more than one egg, in the older women. // ... 507 women and found multiple follicles - the sacs in ...
... those troubled with low bone density, now you can do something ... Denosumab taken twice a year can rejuvenate the density of bones ... of Medicine has reported the effect of this drug after two ... experimental study. 412 women volunteers who had low bone density ...
... important position on the National Health Service’s Mandate, as ... clinics in Britain are ill-equipped to service customers for ... survey conducted to ascertain the exact position of facilities ... services at their clinics had dwindled in comparison with ...
... new study appearing in the February 22 issue of ... significant differences in the effectiveness of the coronary stents ... known to be more effective in easing the examination ... angiography. // ,Such stents also improve the prognosis ...
... researchers might be able to isolates molecule that would ... ,The revolutionary study has been done independently by teams ... they have identified a master protein that shows how ... ,Science (Feb 17) features the two studies in ...
Cached Medicine News:
(Date:7/6/2015)... , July 6, 2015 Moerae Matrix, ... novel therapeutics that target inflammation and fibrosis, today ... M.D., PhD, as Chief Medical Officer. ... development strategy and programs, which include a pipeline ... and fibrotic conditions.  Bill is an accomplished strategist ...
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., a ... including those with rare and orphan inflammatory disease indications, ... U.S. Food and Drug Administration (FDA) to begin a ... acebilustat (CTX-4430), in adult CF patients in the US. ... Europe will be filed soon after. ...
(Date:7/6/2015)... SUNNYVALE, Calif. , July 6, 2015   ... will report financial results for its 2015 second quarter ... after the close of the market. The ... Pacific Time on Thursday, July 23, 2015, to discuss ... Cepheid,s website at http://ir.cepheid.com at least 15 ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... Calif., March 1, 2012 A consistent theme ... relationship, technological innovation and disease treatment is progression.  ... be seen in healthcare IT, which is expected ... to the healthcare industry.  Companies must maintain a ...
... 1, 2012  In a single bound, Nepean Cancer Care ... for its prostate cancer cases to a dramatically faster ... a technique that is even quicker with Elekta,s new ... treated their first patient with prostate cancer using Integrity ...
Cached Medicine Technology:Frost & Sullivan's Global Healthcare Approach Evolves to Contend with Today's Challenges 2Frost & Sullivan's Global Healthcare Approach Evolves to Contend with Today's Challenges 3Australian Clinic Puts Prostate Cancer Radiation Therapy on Fast Track With Elekta VMAT and Integrity Digital Control System 2Australian Clinic Puts Prostate Cancer Radiation Therapy on Fast Track With Elekta VMAT and Integrity Digital Control System 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: